Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel compounds intended for treatment of obesity reported in recent patents

Nov. 3, 2008

FDA grants orphan drug status to Aldagen's ALD-101 stem cell therapy

Oct. 31, 2008

Takeda submits NDA for Actos combination tablet in Japan

Oct. 31, 2008

Karo's phase II study expands the potential for eprotirome in dyslipidemia

Oct. 31, 2008

Recent Japanese patents describe new agents for endocrine-related disorders

Oct. 31, 2008

FDA approves sanofi-aventis' Apidra insulin for diabetic children aged 4 years and older

Oct. 30, 2008

South Africa Medicines Control Council discontinues registration of Biopure's Hemopure

Oct. 30, 2008

Northfield Laboratories submits BLA to FDA for PolyHeme red cell substitute

Oct. 30, 2008

Galenea and Organix enter exclusive license agreement for 5-HT2C agonists

Oct. 29, 2008

Merck Serono submits sNDA for Gonal-f in Japan for ovulation induction

Oct. 28, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...